Sabra Healthcare REIT Inc (SBRA) concluded trading on Thursday at a closing price of $17.33, with 3.14 million shares of worth about $54.48 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -8.28% during that period and on March 20, 2025 the price saw a loss of about -1.59%. Currently the company’s common shares owned by public are about 237.59M shares, out of which, 233.61M shares are available for trading.
Stock saw a price change of 2.79% in past 5 days and over the past one month there was a price change of 4.71%. Year-to-date (YTD), SBRA shares are showing a performance of 0.06% which increased to 23.01% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $13.22 but also hit the highest price of $19.99 during that period. The average intraday trading volume for Sabra Healthcare REIT Inc shares is 2.18 million. The stock is currently trading 2.92% above its 20-day simple moving average (SMA20), while that difference is up 3.25% for SMA50 and it goes to 1.71% higher than SMA200.
Sabra Healthcare REIT Inc (NASDAQ: SBRA) currently have 237.59M outstanding shares and institutions hold larger chunk of about 98.21% of that.
The stock has a current market capitalization of $4.12B and its 3Y-monthly beta is at 0.91. PE ratio of stock for trailing 12 months is 32.36, while it has posted earnings per share of $0.54 in the same period. Its PEG reads 2.29 while making debt-to-equity ratio of 0.89. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SBRA, volatility over the week remained 2.46% while standing at 2.92% over the month.
Stock’s fiscal year EPS is expected to rise by 31.07% while it is estimated to increase by 9.76% in next year. EPS is likely to grow at an annualized rate of 14.14% for next 5-years, compared to annual growth of 7.91% made by the stock over the past 5-years.
Coverage by JMP Securities stated Sabra Healthcare REIT Inc (SBRA) stock as a Mkt outperform in their note to investors on January 07, 2025, suggesting a price target of $20 for the stock. On December 05, 2024, Mizuho Downgrade their recommendations, while on October 01, 2024, Wells Fargo Upgrade their ratings for the stock with a price target of $20. Stock get a Buy rating from Citigroup on September 13, 2024.
